Generic Formulation Products
Therapy Area 
Dosage Form
Dossier Status
En desarrollo
Oral
Sitagliptin HCL + Metformin
Anti-diabético
- 50 + 500
- 50 + 850
Filed
Oral
Sitagliptin HCL
Anti-diabético
- 25
- 50
- 100 mg
Filed
Oral
Sitagliptin Phosphate
Anti-diabético
- 25
- 50 and 100 mg
Filed
Oral
Sitagliptin Phosphate + Metformin
Anti-diabético
- 50 + 500
- 50 + 1000 mg
Filed
Oral
Eltrombopag
Cardiovascular
- 12.5
- 25
- 50 and 75 mg
En desarrollo
Oral
Bempedoic acid Ezetimibe
Cardiovascular
- 180 mg/10 mg
En desarrollo
Oral
Bempedoic acid
Cardiovascular
- 120 mg and 240 mg
En desarrollo
Oral
Edoxaban
Cardiovascular
- 15 mg
- 30 mg and 60 mg